title: Altered megakaryocyte-platelet-haemostatic axis in patients with acute stroke.
abstract: Platelet function is accentuated in acute ischaemic stroke (IS) and may also be altered in haemorrhagic stroke. Whether these changes are a direct reaction to the stroke or are secondary to changes in megakaryocytes (MKs) is unknown. To determine whether MKs are altered in acute stroke we studied 24 patients (18 with ischaemic stroke, six with haemorrhagic stroke) within 3 days of symptom onset, and 14 matched controls. MK ploidy (DNA content, N), size (forward scatter, FSC, arbitrary units), granularity (side scatter, SSC, arbitrary units) and glycoprotein (GP) IIIa expression (arbitrary units) were assessed by flow cytometry. Platelet size (MPV, fl), platelet count (PC, x109/l), circulating reticulated platelets (%), and cutaneous bleeding time (s) were also measured. MK ploidy 22.5 (2.7) vs. 20.6 (1.7) (2p = 0.014); FSC 629 (51) vs. 594 (41) (2p = 0.025); and SSC 843 (88) vs. 776 (76) (2p = 0.020) were each increased, whereas bleeding time 318 (102) vs. 401 (94) (2p = 0.050) was decreased in patients with acute stroke as compared with controls. Trends to increased MK GP IIIa expression and reticulated platelets were also apparent. In a post hoc analysis, the increase in MK ploidy was most prominent in patients with a prior history of hypertension. Ischaemic stroke was associated with non-significant increases in MK ploidy, size, and granularity. However, MK parameters were different in acute haemorrhagic stroke as compared with controls: MK ploidy 23.0 (1.8) vs. 20.6 (1.7) (2p = 0.018); MK FSC 637 (21) vs. 594 (41) (2p = 0.050); MK SSC 872 (41) vs. 776 (76) (2p = 0.020), changes which could be related to the high prevalence of hypertension (83%) in this group. These results demonstrate that pro-thrombotic changes in the megakaryocyte-platelet-haemostatic axis (MPHA) are present in acute stroke. Although megakaryocyte changes are likely, in part, to be secondary to the stroke, they could also precede the stroke and therefore explain some of the increased platelet function observed in acute stroke.
authors.affiliation: Department of Medicine, King's College School of Medicine and Dentistry, Bessemer Road, London SE5 9PJ, UK.
authors.forename: Nicholas M
authors.initials: NM
authors.lastname: Smith
authors.forename: Rohan
authors.initials: R
authors.lastname: Pathansali
authors.forename: Philip M W
authors.initials: PM
authors.lastname: Bath
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001792:Blood Platelets / Q000502:physiology*; D016022:Case-Control Studies; D006470:Hemorrhage / Q000209:etiology; D006487:Hemostasis; D006801:Humans; D039661:Integrin beta3 / Q000378:metabolism; D007511:Ischemia / Q000209:etiology; D008297:Male; D008533:Megakaryocytes / Q000737:chemistry / Q000502:physiology* / Q000648:ultrastructure; D008875:Middle Aged; D011003:Ploidies; D020521:Stroke / Q000145:classification / Q000209:etiology / Q000473:pathology*; D019851:Thrombophilia
chemical_list: D039661:Integrin beta3